Curza Inc

HOME | Curza

Curza Inc was founded in 2016, is headquartered in Salt Lake City, United States, lists 11–50 employees, and has $8.5M in recorded funding across 4 rounds.

Employees
11–50
Founded
2016
Business Model
B2B
Website
curza.com
Total Funding
$8.5M
Last Round
$2.0M GrantMay 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

Curza is a Salt Lake City-based biotechnology company developing novel small-molecule therapeutics to combat antimicrobial resistance (AMR) and infectious diseases. Founded out of University of Utah technology, Curza has built a platform of structurally distinct proprietary drug classes targeting Gram-negative bacterial pathogens, including ESKAPE superbugs. Their lead program, CZ-02, represents a new class of broad-spectrum ribosomal antibiotics with a unique mechanism of action targeting an unexploited binding site. The company also develops antibiofilm antibiotics for infections such as tuberculosis, osteomyelitis, and device-related infections, with a strategy focused on non-dilutive government and foundation funding from NIH, DTRA, and CARB-X.

Summary

Curza Inc is a Biotech company based in Salt Lake City, United States, founded in 2016. It lists 11–50 employees. It has raised $8.5M in total across 4 rounds, most recently a $2.0M Grant round in May 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)May 2024
$2.0M

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Curza Inc on Indexed.vc
<a href="https://indexed.vc/companies/curza-inc"><img src="https://indexed.vc/api/badge/company/curza-inc" alt="Curza Inc on Indexed.vc" width="260" height="76" /></a>